Literature DB >> 3259234

Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: association with reduced growth capacity.

C Wang1, C A Kelleher, G Y Cheng, J Miyauchi, G G Wong, S C Clark, M D Minden, E A McCulloch.   

Abstract

Myelopoietic growth factors are known to influence the growth in culture of malignant blast cells from human Acute Myeloblastic Leukemia (AML). We have used cDNA clones for the factor CSF-1 and its receptor fms to study DNA and RNA from the blasts of 25 AML patients. The CSF-1 gene was always in the germline configuration. CSF-1 mRNA was found in about half the blast populations. The cells were also studied for their growth properties in culture. A highly significant association was found between CSF-1 expression and poor growth in suspension culture. Most blast populations expressed fms; the number of fms expression negative samples was to small to permit the detection of any association between fms expression and growth or any interaction between the effects of the expression of the growth factor and its receptor. We propose that CSF-1 may be an important part of the mechanism determining the balance between self-renewal and determination in AML blast clones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259234     DOI: 10.1002/jcp.1041350119

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.

Authors:  Karen W L Yee; Hsiao-Wei T Chen; David W Hedley; Sue Chow; Joseph Brandwein; Andre C Schuh; Aaron D Schimmer; Vikas Gupta; Deborah Sanfelice; Tara Johnson; Lisa W Le; Jamie Arnott; Mark R Bray; Carolyn Sidor; Mark D Minden
Journal:  Invest New Drugs       Date:  2016-07-12       Impact factor: 3.850

2.  PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.

Authors:  Yukiko Aikawa; Takuo Katsumoto; Pu Zhang; Haruko Shima; Mika Shino; Kiminori Terui; Etsuro Ito; Hiroaki Ohno; E Richard Stanley; Harinder Singh; Daniel G Tenen; Issay Kitabayashi
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

3.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.

Authors:  Mark P Boldin; Konstantin D Taganov; Dinesh S Rao; Lili Yang; Jimmy L Zhao; Manorama Kalwani; Yvette Garcia-Flores; Mui Luong; Asli Devrekanli; Jessica Xu; Guizhen Sun; Jia Tay; Peter S Linsley; David Baltimore
Journal:  J Exp Med       Date:  2011-05-09       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.